Thryv Therapeutics

About:

Thryv Therapeutics is a precision medicine approach to treat patients with Long QT Syndrome and potentially other arrhythmias.

Website: https://thryvtrx.com

Twitter/X: LqtTherapeutics

Top Investors: Fonds de solidarité FTQ, Investissement Quebec, Alexandria Venture Investments, Amplitude Venture Capital, Lumira Ventures

Description:

Thryv Therapeutics is a genetic disorder that causes a prolongation between the beginning of the QRS complex and the end of the T waveQ and T waves on the EKG, indicating a prolongation of ventricular repolarization and the action potential duration. The lengthening of this complex is associated with unexpected and life-threatening ventricular arrhythmias. Click below to learn more about our programs.